Non-germinal Center B-cell-like Diffuse Large B-cell Lymphoma

• CLINICAL_TRIALS research · 2025-02-04
  Clinical Trial Update: Polatuzumab, Rituximab and Orelabrutinib Combination Regimen (PRO) in the Treatment of Elderly Frail Patients with Treatment-naive Non-GCB DLBCL [Phase 2]

  This is a Phase 2 clinical trial evaluating a three-drug regimen of polatuzumab vedotin, rituximab, and orelabrutinib for elderly, frail pat…